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Improving diet and physical activity: 12 lessons from
controlling tobacco smoking
Derek Yach, Martin McKee, Alan D Lopez, Tom Novotny for Oxford Vision 2020
On behalf of Oxford Vision 2020, a partnership dedicated to preventing the forecast worldwide
growth of chronic diseases, the authors suggest that 12 lessons learnt from attempts to control
tobacco smoking could be used to tackle the chronic disease epidemics evolving from unhealthy
diets and a lack of physical activity
This year three new books have been published about
the progress made globally in research, policy, and
actions to control tobacco smoking.1–3 In addition, Sir
Richard Doll reported this year on 50 years of follow-
ing British doctors to document the impact of smoking
on their health.4 We have reviewed the evidence and
approaches taken to control tobacco smoking, well
described in these new texts, because of the rapid glo-
bal increase in the risk factors of unhealthy diets and
lack of physical activity. As part of the Oxford Vision
2020 process,5 we have proposed 12 lessons from
tobacco control that might speed up progress in tack-
ling these new public health threats. We also drew on
other recent insights from tobacco control in address-
ing other chronic disease risks.6–8
1. Address the issue of individual
responsibility versus collective or
environmental action early and often
This issue pervades debates on the role of government
versus that of the individual, and both sides of the
issue need to be addressed. However, the World
Health Organization’s statement in its Ottawa charter
remains valid: “Healthy choices need to be the easy
choices.”9 Individual responsibility can have its full
effect only in a society where governments, private
interests, and other sectors work together to support
individuals making healthy choices. In all societies
special support is required for children, who are
neither competent nor legally able to make fully
informed decisions about behaviours with lifelong
effects on their health.
2. Evidence of harm is necessary, but is
not sufficient to motivate policy change
Although sufficient evidence exists to guide clear
policies on, for example, reducing salt, sugar, and fat in
the diet and promoting physical activity, some
essential epidemiological gaps need to be closed in
relation to diets and outcomes in developing
countries. This uncertainty in some areas and the
resulting call for more research may be used to delay
policy change, and some interested parties will
probably continue to dispute the evidence. Undertak-
ing research necessary to close the remaining
knowledge gaps is therefore important to eliminate
any persisting uncertainty, particularly with regard to
the health effects of obesity.
3. Decisions to act need not wait for
evidence of the effectiveness of
interventions
Initial tobacco control interventions were not evidence
based but represented sound judgment at the time. It is
now clear from this experience that actions such as
restrictions on advertising, pricing interventions, and
broad community projects can be effective at changing
behaviour. This knowledge and an intuitive approach
should enable us to develop interventions for diet and
physical activity. This should be done in such a way that
they can be critically evaluated in terms of effective-
ness, and adjustments made over time. Oxford Vision
2020 is planning to develop scalable demonstration
projects on this basis.
4. Fully implement interventions known
to be effective
Identification of effective methods for stopping smok-
ing has not led to their widespread use. To decrease
chronic disease mortality and severity by 2020, we
need to increase rates of stopping smoking among
current smokers and of weight loss among those who
are overweight or obese and improve diets in other
ways. Stopping initiation of smoking and reversing
trends in childhood obesity will only have an impact
well beyond 2020.
Stopping smoking leads to rapid reductions in mor-
tality from cardiovascular disease: the excess risk roughly
halved after one year of smoking abstinence. Barriers to
implementing programmes for stopping smoking need
Increasingly, developing countries need to tackle obesity and
associated chronic diseases as well as hunger and undernutrition
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to be urgently addressed, such as the lack of training by
healthcare workers; limited infrastructure to support
interventions; reimbursement issues for counselling,
drugs, and intervention dissemination; and smokers’
hesitancy to use drugs to help quit.
There is evidence of the beneficial effects of reducing
serum cholesterol concentrations and increasing physi-
cal activity on cardiovascular disease, reducing salt intake
on hypertension, and increasing fruit and vegetable
intake on diabetes. For obesity, we currently lack
evidence of effective interventions. A strategy should be
developed to address obesity as a chronic relapsing dis-
order that may require several weight loss attempts and
the use of effective drugs that are developed in collabo-
ration with the public health community.
5. Real and perceived needs and
concerns of developing countries need
to be addressed even if they involve
going beyond the initial scope of the risk
being addressed
For tobacco control, this has meant addressing all
forms of tobacco use, not just cigarettes, and consider-
ing the concerns of tobacco farmers and providing
convincing evidence that their livelihoods were not
under threat in the mid-term.
With regard to diet and nutrition, the needs and
concerns of developing countries will be more complex.
Close interaction will be needed between those working
to address hunger, micronutrient deficiencies, and
undernutrition in general and those working to develop
policies for overweight and chronic disease prevention.
The goal should be to promote the optimal diets for all.
It also requires that greater attention be paid to the
complex agricultural and economic issues related to
subsidies and decisions about what is cultivated.
6. The more comprehensive the package
of measures considered, the greater the
impact
Narrow approaches tend to be emphasised currently
in relation to diet and physical activity—more exercise
at schools, more education at work, etc. Few take a
broad perspective.
Those implementing a comprehensive package of
measures to control tobacco or improve diet and
physical activity need to understand where govern-
ments are constrained in their actions in order to help
them find solutions. For example, some countries have
a constitutional impediment to a complete ban on
tobacco advertisements: a way round this is to support
them going to the limit of their law and at the same
time investing more in effective counter-advertising.
It is important to avoid dissecting comprehensive
programmes in attempts to ascertain the effectiveness
of individual components. The components work
together to create a social and policy milieu that works
collectively rather than as separate elements.
7. Broad based, well networked, vertical
and horizontal coalitions are key
Vertical coalitions include all levels of health services—
from local health departments to regional and national
authorities to WHO. It is increasingly clear that a wide
array of players outside the traditional boundaries of
health care need to be engaged and, often, encouraged
to take the lead on certain aspects of the problem. But
health workers still need to provide overall direction
and leadership. This has been achieved for WHO’s
Framework Convention on Tobacco Control in the
United Nations, among non-governmental organisa-
tions, and, to a limited extent, across departments in
many governments. More needs to be done for diet
and physical activity, however.
8. Change in support for tobacco control
took decades of effort led by media
savvy and politically astute leaders
The global breakthrough came with Gro Harlem
Brundtland’s willingness, as director general of WHO,
to tackle an unpopular topic, speaking out often about
smoking as a real global concern to heads of state,
major donors, and those in industry. But progress had
been made since the 1960s through the reports of the
Royal College of Physicians and of the US surgeon
general to develop the scientific basis for the content of
the Framework Convention on Tobacco Control. Key
networks of advocates and non-governmental organi-
sations were thus empowered to support this first ever
international health treaty. Such international interest
has happened to only a limited extent in relation to
diet and physical activity.
9. Modest, well spent funds can have a
massive impact, but without clear goals
funding may not be sustainable
Some countries have set targets for tobacco control but
then not resourced their attainment. For both tobacco
and diet there are no agreed targets or internationally
accepted indicators of progress. A global initiative to
develop these for selected countries could be extremely
useful; the figures could also be used for advocacy and
budgetary purposes. Ministries of finance and ministries
of health alike need evidence for allocating scarce funds
for preventive health interventions. It is far easier to fund
medical care systems than prevention programmes, but
the broad effects of secondary and tertiary medical care
interventions are far less cost effective than preventive,
policy based interventions on tobacco control. This
understanding needs to extend to diet and obesity con-
trol programmes.
10. Complacency that past actions will
serve well in future may retard future
progress
Despite all the progress in tobacco control, the bottom
line remains that global consumption continues to
increase, albeit slowly. Few countries have achieved sus-
tained reductions in smoking prevalence of more than
2% a year for a decade (though South Africa has
reported a 6% decline a year for eight years). The abil-
ity to achieve only slow rates of decline when dealing
with such a huge public health problem means that we
need to look afresh at our policies and interventions.
We must consider what is needed to reach an annual
decline of 8-10% and then to maintain smoking
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prevalence well below 10% in all social classes and
ethnic subgroups.
A stronger emphasis on smoke-free policies
combined with increased tobacco prices and greater
access to aids to stopping smoking could certainly
achieve higher levels of decline in per capita tobacco
consumption. New approaches, including the use of
plain packaging and health oriented trade policy, need
to be considered as well.
For diet, and especially obesity, there is still insuffi-
cient research of community based interventions to
show best practices. Investment in large scale, commu-
nity based research is needed to yield evidence of
progress against obesity and other adverse outcomes
of poor diet and physical inactivity.
11. Rules of engagement with the
tobacco and food industries need to be
different and continually under review
In recent years the public health community has not
officially met with the tobacco industry, with the excep-
tion of the US Centers for Disease Control and
Prevention and WHO in their recorded discussions
about product regulation. This reflects concerns about
the tobacco industry’s longstanding efforts to manipu-
late and distort scientific evidence, as revealed by its
internal documents released during US litigation.10
While constructive dialogue with the tobacco
industry remains only a distant prospect, until they can
show incontrovertibly that they have changed, engage-
ment with the food industry is different as, unlike
tobacco, food is not a product that is harmful when
used as intended. Here, there is scope for shared
exploration of issues such as marketing to children,
joint action to promote physical activity and healthy
eating, and support for priority research—although it is
important to recognise that, even for responsible
industries, commercial pressures exist, and observation
of the tobacco industry indicates the need for effective
vigilance. Oxford Vision 2020, with selected others
such as the International Business Leaders Forum,
could provide leadership in developing consultations
involving governments, non-governmental organisa-
tions, the food industry, and academia.
12. Risk factor envy is harmful—a joint
approach is needed
As the media and others have focused on obesity, less
attention has been paid to tobacco smoking. Agencies
that fund public health research and interventions may
be shifting their funding criteria as a consequence.
There seems to be a tendency to focus on one major
public health problem at a time, and thus a
competition for attention and funding develops. We
urgently need to build synergies rather than competi-
tion between those active in tobacco control and those
addressing diet and physical activity. It is important to
consider not only the death toll from specific causes
but to develop a holistic approach to public health that
includes multiple risk factors. A grand coalition of the
interested parties could do more good for changing
public health policy than they could working in
isolation from each other.
We thank Oxford Vision 2020 for supporting the Tobacco
Working Group and, in particular, its co-sponsors the University
of Oxford and Novo Nordisk A/S.
Contributors: DY has worked in public health policy at national
and international level for two decades. At WHO, he has been
involved in the Health For All strategy; the Framework Conven-
tion on Tobacco Control; a global strategy for diet, physical
activity, and health; and a new strategy on non-communicable
diseases. MMcK manages a large research programme on
health and healthcare involving many European countries and
has been editor in chief of the European Journal of Public Health.
TN has been a World Bank public health consultant on health
systems reform; worked in the US Public Health Service, serving
as assistant surgeon general and deputy assistant secretary for
international and refugee health; and has published widely on
tobacco control, HIV/AIDS, and public health practice. ADL
worked at WHO for 22 years and has been chief epidemiologist
and head of the tobacco programme. He has published widely
on mortality analysis and causes of death and is coauthor of
Global Burden of Disease Study.
Funding: DY has been a paid consultant to the Oxford Vision
project (jointly funded by Oxford University and Novo Nordisk),
and Oxford Vision support was important to the preparation of
this article. MMcK has received travel expenses to attend Oxford
Vision 2020 meetings from Novo Nordisk. TN received support
from University of California San Francisco, the National Insti-
tutes of Health, the Centers for Disease Control and Prevention,
and the European Commission.
Competing interests: None declared beyond funding.
1 Boyle P, Gray N, Henningfeld J, Seffrin J, Zatonski W, eds. Tobacco and
public health: science and policy. Oxford: Oxford University Press, 2004.
2 IARC Working Group on the Evaluation of Carcinogenic Risks to
Human Health. Tobacco smoke and involuntary smoking. Lyons:
International Agency for Research on Cancer, 2004. (IARC monograph
83.)
3 Feldman EA, Beyer R. Unfiltered: conflicts over tobacco policy and public
health. Cambridge, MA: Harvard University Press, 2004.
4 Doll R, Peto R, Boreham J, Sunderland I.Mortality in relation to smoking:
50 years’ observations of male British doctors. BMJ 2004;328:1519-28.
5 Learning from tobacco to address diet and nutrition more effectively.
Tobacco Working Group report. Oxford Vision 2020, 2004.
www.oxfordvision2020.org/getMedia.asp?mb_GUID = 4B5356F7-1E61-
4380-AACB-0EC1B3CE3E31.ppt (accessed 21 Mar 2005).
6 Chopra M, Darnton-Hill I. Tobacco and obesity epidemics: not so differ-
ent after all? BMJ 2004;328:1558-60.
7 Yach D, Hawkes C, Epping-Jordan JE, Galbraith S. The World Health
Organization’s framework convention on tobacco control: implications
for the global epidemics of food-related deaths and disease. J Public
Health Policy 2004;24:274-90.
8 Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic
diseases: overcoming impediments to prevention and control. JAMA
2004;291:2616-22.
9 World Health Organization. Ottawa charter for health promotion. Geneva:
WHO, 1986.
10 Glantz SA, Slade J, Bero LA, Hanauer P, Barnes DE, eds. The cigarette
papers. Berkeley, CA: University of California Press, 1996.
Summary points
Progress in tobacco control required high level,
sustained advocacy and political acumen;
progress in addressing obesity will require the
same
Tobacco smoking remains a major global threat
despite a shift in media attention
Opportunities for joint approaches to nutrition
and tobacco related health problems have been
neglected
The potential for positive interaction with the
food industry in finding common solutions
remains high provided the industry shows
transparency
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